Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Research

Showing 11 - 20 of 28 Results.

Direct-to-Consumer Advertising and the Demise of the Ideal Model of Health Care
Ronald F. White | The Independent Review | Fall 2006
Weakened Immunity
How the Food and Drug Administration Caused Recent Vaccine-Supply Problems
Arthur E. Foulkes | The Independent Review | Summer 2004
Do Off-Label Drug Practices Argue Against FDA Efficacy Requirements?
Testing an Argument by Structured Conversations with Experts
Alexander T. Tabarrok, Daniel B. Klein | Working Paper | Oct. 2, 2003
We Favor a Freer Market in Kidneys
Deborah Walker, Michael Saliba, William Barnett II | The Independent Review | Spring 2003
The Blessed Monopolies
Does pediatric exclusivity drug legislation benefit children? What about their parents?
Alexander T. Tabarrok | Research Article | Dec. 1, 2001
Public Health and the Placebo
The Legacy of the 1906 Pure Food and Drug Act
Russell S. Sobel | Working Paper | Apr. 3, 2001
The Therapeutic State
The Tyranny of Pharmacracy
Thomas S. Szasz | The Independent Review | Spring 2001
A Free Market in Kidneys
Efficient and Equitable
Deborah Walker, Michael Saliba, William Barnett II | The Independent Review | Winter 2000/01
Monopolies for Children? Pediatric Exclusivity and the Orphan Drug Act
Alexander T. Tabarrok | Research Article | Dec. 13, 2000
Medicare Reform
Economics versus Politics
Robert B. Helms | The Independent Review | Fall 2000






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL